169 related articles for article (PubMed ID: 34171527)
1. Platelet-rich fibrin as a treatment option for osteoradionecrosis: A literature review.
Harris P; Durand R; Schmittbuhl M; Kabir R
J Stomatol Oral Maxillofac Surg; 2022 Jun; 123(3):e20-e27. PubMed ID: 34171527
[TBL] [Abstract][Full Text] [Related]
2. Interventions for preventing osteoradionecrosis of the jaws in adults receiving head and neck radiotherapy.
El-Rabbany M; Duchnay M; Raziee HR; Zych M; Tenenbaum H; Shah PS; Azarpazhooh A
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31745986
[TBL] [Abstract][Full Text] [Related]
3. Autogenous free fat graft combined with platelet-rich fibrin heals a refractory mandibular osteoradionecrosis.
Law B; Mohd Yunus SS; Ramli R
Clin Ter; 2020; 171(2):e110-e113. PubMed ID: 32141481
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte- and platelet-rich fibrin does not provide any additional benefit for tooth extraction in head and neck cancer patients post-radiotherapy: a randomized clinical trial.
Palma LF; Marcucci M; Remondes CM; Chambrone L
Med Oral Patol Oral Cir Bucal; 2020 Nov; 25(6):e799-e804. PubMed ID: 32701929
[TBL] [Abstract][Full Text] [Related]
5. Autologous platelet concentrates in extraction sockets for the prevention of osteoradionecrosis: a systematic review of controlled clinical trials.
Serrano RV; Gomes TP; da Silva FM; Chambrone L; Marques MM; Palma LF
Oral Maxillofac Surg; 2022 Dec; 26(4):555-561. PubMed ID: 35048208
[TBL] [Abstract][Full Text] [Related]
6. The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline.
Sultan A; Hanna GJ; Margalit DN; Chau N; Goguen LA; Marty FM; Rabinowits G; Schoenfeld JD; Sonis ST; Thomas T; Tishler RB; Treister NS; Villa A; Woo SB; Haddad R; Mawardi H
Oncologist; 2017 Mar; 22(3):343-350. PubMed ID: 28209748
[TBL] [Abstract][Full Text] [Related]
7. Prevention and Management of Osteoradionecrosis in Patients With Head and Neck Cancer Treated With Radiation Therapy: ISOO-MASCC-ASCO Guideline.
Peterson DE; Koyfman SA; Yarom N; Lynggaard CD; Ismaila N; Forner LE; Fuller CD; Mowery YM; Murphy BA; Watson E; Yang DH; Alajbeg I; Bossi P; Fritz M; Futran ND; Gelblum DY; King E; Ruggiero S; Smith DK; Villa A; Wu JS; Saunders D
J Clin Oncol; 2024 Jun; 42(16):1975-1996. PubMed ID: 38691821
[TBL] [Abstract][Full Text] [Related]
8. Osteoradionecrosis of the jaws: definition, epidemiology, staging and clinical and radiological findings. A concise review.
Chronopoulos A; Zarra T; Ehrenfeld M; Otto S
Int Dent J; 2018 Feb; 68(1):22-30. PubMed ID: 28649774
[TBL] [Abstract][Full Text] [Related]
9. Timing of dental extractions in patients undergoing radiotherapy and the incidence of osteoradionecrosis: a systematic review and meta-analysis.
Beaumont S; Bhatia N; McDowell L; Fua T; McCullough M; Celentano A; Yap T
Br J Oral Maxillofac Surg; 2021 Jun; 59(5):511-523. PubMed ID: 33685773
[TBL] [Abstract][Full Text] [Related]
10. Osteoradionecrosis in cancer patients: the evidence base for treatment-dependent frequency, current management strategies, and future studies.
Peterson DE; Doerr W; Hovan A; Pinto A; Saunders D; Elting LS; Spijkervet FK; Brennan MT
Support Care Cancer; 2010 Aug; 18(8):1089-98. PubMed ID: 20526784
[TBL] [Abstract][Full Text] [Related]
11. Use of platelet-rich fibrin and surgical approach for combined treatment of osteoradionecrosis: a case report.
Chen YT; Chang YC
J Int Med Res; 2019 Aug; 47(8):3998-4003. PubMed ID: 31354001
[TBL] [Abstract][Full Text] [Related]
12. Osteoradionecrosis of the jaw bones at the University of Kentucky Medical Center.
Patel P; Raybould T; Maruyama Y
J Ky Med Assoc; 1989 Jul; 87(7):327-31. PubMed ID: 2754311
[TBL] [Abstract][Full Text] [Related]
13. Is there a role for PRF with simvastatin in stage I osteoradionecrosis?
Baliga M; Chakraborty S; Kumari T; Tusharbhai DM; Sarkar S
Oral Oncol; 2018 Dec; 87():177-178. PubMed ID: 30527236
[No Abstract] [Full Text] [Related]
14. [Clinical analysis of mandibular osteoradionecrosis].
Matsuo M; Rikimaru F; Higaki Y; Tomita K
Nihon Jibiinkoka Gakkai Kaiho; 2010 Dec; 113(12):907-13. PubMed ID: 21409817
[TBL] [Abstract][Full Text] [Related]
15. Osteoradionecrosis of the mandible after radiotherapy for head and neck cancer: risk factors and dose-volume correlations.
Aarup-Kristensen S; Hansen CR; Forner L; Brink C; Eriksen JG; Johansen J
Acta Oncol; 2019 Oct; 58(10):1373-1377. PubMed ID: 31364903
[No Abstract] [Full Text] [Related]
16. Osteoradionecrosis of the skull base.
Leonetti JP; Weishaar JR; Gannon D; Harmon GA; Block A; Anderson DE
J Neurooncol; 2020 Dec; 150(3):477-482. PubMed ID: 32394326
[TBL] [Abstract][Full Text] [Related]
17. Recurrent Malignancy in Osteoradionecrosis Specimen.
Marwan H; Green JM; Tursun R; Marx RE
J Oral Maxillofac Surg; 2016 Nov; 74(11):2312-2316. PubMed ID: 27235177
[TBL] [Abstract][Full Text] [Related]
18. Osteoradionecrosis: causes and prevention.
Friedman RB
NCI Monogr; 1990; (9):145-9. PubMed ID: 2188152
[TBL] [Abstract][Full Text] [Related]
19. Refining the definition of mandibular osteoradionecrosis in clinical trials: The cancer research UK HOPON trial (Hyperbaric Oxygen for the Prevention of Osteoradionecrosis).
Shaw R; Tesfaye B; Bickerstaff M; Silcocks P; Butterworth C
Oral Oncol; 2017 Jan; 64():73-77. PubMed ID: 28024727
[TBL] [Abstract][Full Text] [Related]
20. A systematic review and meta-analysis of osteoradionecrosis following proton therapy in patients with head and neck cancer.
Chiu KW; Yu TP; Kao YS
Oral Oncol; 2024 Jan; 148():106649. PubMed ID: 38035508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
